Ammonia → 2,5-difluoro-4-[2-pyridazin-4-yl-4-(trifluoromethyl)phenoxy]-N-1,2,4-thiadiazol-5-ylbenzenesulfonamide

HRID 1692216

Reaktionsgleichung

Reaktionsgleichung von HRID 1692216
COC1C=C(OC)C=CC=1C[N:6]([C:19]1[S:23][N:22]=[CH:21][N:20]=1)[S:7]([C:10]1[CH:15]=[C:14]([F:16])[C:13](F)=[CH:12][C:11]=1[F:18])(=[O:9])=[O:8].[N:30]1[CH:35]=[CH:34][C:33]([C:36]2[CH:41]=[C:40]([C:42]([F:45])([F:44])[F:43])[CH:39]=[CH:38][C:37]=2[OH:46])=[CH:32][N:31]=1.C(=O)([O-])[O-].[K+].[K+].Cl.FC(F)(F)C(O)=O.N>CN(C)C=O.ClCCl.CO>[F:18][C:11]1[CH:12]=[C:13]([O:46][C:37]2[CH:38]=[CH:39][C:40]([C:42]([F:43])([F:44])[F:45])=[CH:41][C:36]=2[C:33]2[CH:34]=[CH:35][N:30]=[N:31][CH:32]=2)[C:14]([F:16])=[CH:15][C:10]=1[S:7]([NH:6][C:19]1[S:23][N:22]=[CH:21][N:20]=1)(=[O:8])=[O:9]

Komponenten

10

Versuchsvorschrift

The mixture of N-(2,4-dimethoxybenzyl)-2,4,5-trifluoro-N-1,2,4-thiadiazol-5-ylbenzenesulfonamide (Preparation 647, 44 mg, 0.10 mmol), 2-pyridazin-4-yl-4-(trifluoromethyl)phenol (Preparation 712, 34 mg, 0.10 mmol), and potassium carbonate (55 mg, 0.40 mmol) in N,N-dimethylformamide (1.0 ml) was stirred at room temperature for 24 hours. The reaction mixture was poured into aqueous 2 M hydrochloric acid solution (5.0 ml) and filtered to give a solid. The solid was dissolved in dichloromethane (1.0 ml) and trifluoroacetic acid (1.0 ml) was added to the solution. The resulting solution was stirred for 16 hours. Methanol (5.0 ml) was added to the reaction mixture and filtered off polymeric solid. The filtrate was concentrated in vacuo to give a residue. The residue was passed through a 5 g SCX™ column with 1:1 dichloromethane:methanol solution and then 1:0.75:0.25 dichloromethane:methanol:7N ammonia solution in methanol. The filtrate was concentrated in vacuo and purified by HPLC. Yield 7.3 mg, 14%.

Aufarbeitung

  1. filtrationfiltered
  2. customto give a solid
  3. stirringThe resulting solution was stirred for 16 hours
  4. filtrationfiltered off polymeric solid
  5. concentrationThe filtrate was concentrated in vacuo
  6. customto give a residue
  7. concentrationThe filtrate was concentrated in vacuo
  8. custompurified by HPLC

Quellen und Nachweise

ORD-Eintrag
ord-e78a27e210c24548a8e85b9ef76c3100
Quelldatensatz
uspto-grants-2012_04
Patentnummer
US08153814B2

Verknüpfte Notizen

Wird geladen…